A disruptive technology to tackle brain cancer and glioblastoma
News
Improving local control of glioblastoma: Hemerion technology presented at the 2023 Congress of the French Society of Neurosurgery
Maximilien Vermandel and Prof. Nicolas Reyns are organizing a demonstration of the Hemerion technology associated with the surgical treatment of glioblastoma during the 2023 Congress of the French Society of… ...
Prof. Costas Hadjipanayis named head of the University of Pittsburgh (UPMC) Image-Guided Neurosurgery Center
Professor Costas Hadjipanayis, a member of Hemerion's Scientific Advisory Board, has been appointed head of several neurosurgery centers at the University of Pittsburgh in the USA. An active member of… ...
Hemerion continues to grow and inaugurates its new premises
Two years after its launch, Hemerion Therapeutics inaugurated its new premises on Thursday, October 20. Located in Villeneuve d’Ascq in the North of France, Hemerion Headquarters houses the team in… ...

Stay tuned to our clinical advances